Table 2.
Nucleocytoplasmic mechanisms of aggressive melanoma and thyroid cancer.
Signal Transducer | Translocation Effects | Oncogenic Role | Specific Cancer | References |
---|---|---|---|---|
FOXO1, FOXO3a, FOXO4, FOXO6 | Cytoplasmic mislocalization promoted by Akt. Nuclear localization of Akt in thyroid cells increases oncogenic expression, high metastatic invasion in lymph nodes and tumor aggression | Activate transcription of genes that triggers cellular proliferative, cell cycle, differentiation, and cell death. | Melanoma, thyroid cancer | Kau et al., 2004; Tang et al., 1999, Takaishi et al., 1999; Nakamura et al., 2000 |
Claudin-1 | Translocation from nucleus to cytoplasm in melanoma cells and increased cytoplasmic expression in a PKC-dependent manner but altered migration by PKA Phosphorylation. | Increased expression, invasiveness in melanoma hence a marker of progression | Melanoma | French et al., 2009; Leotlela et al., 2007 |
B-catenin | Nuclear expression | Tumor suppressor role in primary and secondary tumors | Melanoma, thyroid cancer | Chien et al., 2009 |
Cyclin D1 | Cytoplasmic claudin-1 is highly expressed with more aggression and increased invasiveness in melanoma unlike benign nuclear claudin-1 | Accumulation of cells in the G1 phase of cell cycle. | Melanoma | French et al., 2009; Leotlela et al., 2007 |
CDKN1B (p27) | Phosphorylated by Akt and exported from nucleus to cytoplasm. Cytoplasmic expression is associated with poor 5-year survival in metastatic melanoma | A cell-cycle inhibitor, blocks cell cycle in the G0/G1 differentiation signals or cellular stress —cell cycle, activation of PI3K and MEK-dependent kinases | Thyroid, melanoma | Kau et al., 2004 |
p53 | Mutation, post-translational modification, or cytoplasmic mislocalization | Acts as a tumor suppressor and trigger cell cycle arrest, apoptosis, senescence, DNA repair, DNA damage and change the metabolism depending on physiological conditions. Also, known as Guardian of the genome. | Melanoma | Fabbro & Henderson, 2003; Webster et al., 2019 |
NF-kB | Nuclear import of NF-κB leads to increased target gene expression leading to promotion of tumorigenesis and resistance to anticancer therapies | Activate NF-kB signaling and induce apoptosis of cancer cells. | Thyroid cancer | Kau et al., 2004 |
Muc 1/EGFR | MUC1 confers survival advantage in melanoma, overexpression of EGFR and nuclear mislocalization is associated with aggressiveness | Induce oncogene expression through interaction with β-catenin and EGFR. | Melanoma and thyroid cancer | Zhao et al., 2014; Patel et al., 2005; Ward et al., 2007 |